Abiopharma

🔍 Eberwein Jeffrey E. (Director)

Company: Star Equity Holdings, Inc. (STRR)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 5,000 shares of Common Stock. at $11.01 per share (Direct)
  Date: 2026-06-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,120,714.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 5,000 shares of Common Stock. at $11.01 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,125,714.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Includes (i) 21,125 shares of restricted stock credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated; (ii) 6,750 RSUs; and (iii) 1,092,839 shares of common stock. Excludes 2,000 shares indirectly owned in contributory 401(k) and IRA accounts. Each share of restricted stock and each RSU represents the right to receive, at settlement, one share of common stock.
• F2: Includes (i) 21,125 shares of restricted stock credited to the Reporting Person's account under the Issuer's 2009 Incentive Stock and Awards Plan, as amended and restated; (ii) 6,750 RSUs; and (iii) 1,097,839 shares of common stock. Excludes 2,000 shares indirectly owned in contributory 401(k) and IRA accounts. Each share of restricted stock and each RSU represents the right to receive, at settlement, one share of common stock.